Tag: Pfizer
Pfizer INDovation program boosts six healthcare startups with INR 1.5 Crore...
The Pfizer INDovation NIPER-A edition is supported by Pfizer Limited, and the Department of Pharmaceuticals, NITI Aayog, NIPER-Ahmedabad and Social Alpha as anchor partners to back indigenous healthcare solutions to advance India’s healthcare priorities
HCMCT Manipal Hospital partners with Pfizer to launch adult vaccination centre...
The Centre aims to enhance protection against vaccine-preventable diseases, focusing on adult vaccination in high-risk populations
Lakshmanan Krishnakumar and Sonia Singh join Pfizer as Independent Directors
The new board members bring extensive expertise in finance and marketing from leadership roles in top companies
Artemis Hospitals and Pfizer India launch Adult Vaccination Centre
The new centre aims to offer comprehensive education and promote timely immunization to reduce disease-related mortality in adults
Pfizer and Amrita Hospital launch Centre of Excellence for adult vaccination...
The initiative aims to boost community protection against vaccine-preventable diseases with enhanced adult vaccination efforts
Pfizer’s LORBRENA achieves 60% five-year survival in ALK-positive lung cancer
Phase 3 CROWN trial shows 81% reduction in progression risk and 94% fewer brain metastases compared to XALKORI®
GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in...
The European Medicines Agency (EMA) recently accepted the company’s regulatory application to expand the use of Arexvy and a decision is anticipated in H2 2024
KIMS Hospitals and Pfizer collaborate to unveil CoE for Adult Vaccination...
Through this CoE, KIMs and Pfizer want to make a substantial contribution to respiratory health in Hyderabad and Telangana, aligning with the broader national and global efforts to combat the rising impact of infectious diseases and respiratory illnesses
Alnylam patent lawsuit against Pfizer, Moderna highlights escalating legal pressure on...
The potential for lucrative settlements in the multi-billion-dollar COVID-19 vaccine market adds further significance to these legal battles
Pfizer acquires Seagen for US$ 43 billion to develop better cancer...
Proposed combination enhances Pfizer’s position as a leading company in oncology